{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "G",
                    "alt": "R",
                    "position": "2385"
                },
                "variant_string_id": "LRRK2 G2385R"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the pars compacta of the substantia nigra. The discovery of LRRK2 as a causative PD gene has provided insights into the pathophysiology of both familial and sporadic forms of the disease. Dominant missense mutations of LRRK2 act via a toxic gain of function mechanism coupled with an increase in kinase activity.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly describes the disease mechanism of PD and how LRRK2 mutations are involved in it, specifically through a toxic gain - of - function mechanism related to kinase activity.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "In vitro kinase assay was performed to determine the kinase activities of the variants.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro kinase assay effectively models the disease pathogenesis as the disease mechanism involves changes in kinase activity of LRRK2.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "In control assays, established kinases showed specific phosphorylation of their specific substrate. The experiments were performed with n = 4 independent experiments.",
                    "judgment": "Yes",
                    "reasoning": "Both normal (vector control) and abnormal (established kinases) controls were used, and the paper explicitly states that n = 4 independent experiments (replicates) were used.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "Wild - type (WT) was used as a control. Also, p.R1398H (a variant with decreased kinase activity) was used in the study, which can be considered as a control relevant to the variant's effect on kinase activity.",
                    "judgment": "Yes",
                    "reasoning": "Wild - type and a variant with different kinase activity were used as controls, meeting the criteria for variant controls.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation - Sub - step 4a: Statistical Analyses",
                    "extracted_paper_info": "The autokinase activities of WT, p.R1628P, and p.G2385R were significantly higher than vector control, with p.G2385R showing higher activity compared to WT at p < 0.05. Signals were analyzed using ImageQuant TL analysis software.",
                    "judgment": "Yes",
                    "reasoning": "Statistical analyses including p - values were used to compare the kinase activity of the variant with controls, which can be used to estimate OddsPath.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation - Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "The autokinase activity of p.G2385R was significantly higher than WT at p < 0.05. Although OddsPath is not directly given, the significant increase in kinase activity relative to WT indicates a high likelihood of pathogenicity.",
                    "judgment": "PS3_moderate",
                    "reasoning": "Based on the significant increase in kinase activity compared to WT, assuming standard ACMG OddsPath thresholds, it can be inferred that the OddsPath is in the moderate range for pathogenicity (as the increase is significant but no very high - level quantification like OddsPath > 18.7 is provided).",
                    "next_step_or_outcome": "Final assessment"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_moderate"
            },
            "overall_conclusion": "The functional evidence for LRRK2 G2385R is considered PS3_moderate because the disease mechanism is clearly defined, the in vitro kinase assay is applicable, proper controls and replicates were used, variant controls were present, statistical analyses were sufficient, and the significant increase in kinase activity relative to WT indicates a moderate level of pathogenicity likelihood."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "P",
                    "position": "1628"
                },
                "variant_string_id": "LRRK2 R1628P"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the pars compacta of the substantia nigra. The discovery of LRRK2 as a causative PD gene has provided insights into the pathophysiology of both familial and sporadic forms of the disease. Dominant missense mutations of LRRK2 act via a toxic gain of function mechanism coupled with an increase in kinase activity.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly describes the disease mechanism of PD and the role of LRRK2 mutations in it through a toxic gain - of - function mechanism related to kinase activity.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "In vitro kinase assay was performed to determine the kinase activities of the variants.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro kinase assay is relevant as the disease mechanism involves changes in LRRK2 kinase activity.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "In control assays, established kinases showed specific phosphorylation of their specific substrate. The experiments were performed with n = 4 independent experiments.",
                    "judgment": "Yes",
                    "reasoning": "Both normal (vector control) and abnormal (established kinases) controls were used, and the paper explicitly states that n = 4 independent experiments (replicates) were used.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "Wild - type (WT) was used as a control. Also, p.R1398H (a variant with decreased kinase activity) was used in the study, which can be considered as a control relevant to the variant's effect on kinase activity.",
                    "judgment": "Yes",
                    "reasoning": "Wild - type and a variant with different kinase activity were used as controls, meeting the criteria for variant controls.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation - Sub - step 4a: Statistical Analyses",
                    "extracted_paper_info": "The autokinase activities of WT, p.R1628P, and p.G2385R were significantly higher than vector control, with p.R1628P showing higher activity compared to WT at p = 0.07. Signals were analyzed using ImageQuant TL analysis software.",
                    "judgment": "Yes",
                    "reasoning": "Statistical analyses including p - values were used to compare the kinase activity of the variant with controls, which can be used to estimate OddsPath.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation - Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "The autokinase activity of p.R1628P was significantly higher than WT at p = 0.07. Although OddsPath is not directly given, the increase in kinase activity relative to WT indicates a likelihood of pathogenicity.",
                    "judgment": "PS3_supporting",
                    "reasoning": "Based on the increase in kinase activity compared to WT, assuming standard ACMG OddsPath thresholds, the relatively lower significance level (p = 0.07) suggests that the OddsPath is in the supporting range for pathogenicity (not as strong as a highly significant increase).",
                    "next_step_or_outcome": "Final assessment"
                }
            ],
            "final_evidence_strength": {
                "type": "Pathogenic",
                "strength": "PS3_supporting"
            },
            "overall_conclusion": "The functional evidence for LRRK2 R1628P is considered PS3_supporting because the disease mechanism is clearly defined, the in vitro kinase assay is applicable, proper controls and replicates were used, variant controls were present, statistical analyses were sufficient, and the increase in kinase activity relative to WT indicates a supporting level of pathogenicity likelihood."
        },
        {
            "variant_id": {
                "Gene": "LRRK2",
                "Protein_Change": {
                    "ref": "R",
                    "alt": "H",
                    "position": "1398"
                },
                "variant_string_id": "LRRK2 R1398H"
            },
            "functional_evidence_aim": "Benign",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "Parkinson disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons in the pars compacta of the substantia nigra. The discovery of LRRK2 as a causative PD gene has provided insights into the pathophysiology of both familial and sporadic forms of the disease. Reducing kinase function of LRRK2 ameliorates cellular toxicity.",
                    "judgment": "Yes",
                    "reasoning": "The paper clearly describes the disease mechanism of PD and how changes in LRRK2 kinase function are related to the disease, with reduced kinase function being associated with a protective effect.",
                    "next_step_or_outcome": "Proceed to Step 2"
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "In vitro kinase assay was performed to determine the kinase activities of the variants.",
                    "judgment": "Yes",
                    "reasoning": "The in vitro kinase assay effectively models the disease pathogenesis as the disease mechanism involves changes in LRRK2 kinase activity.",
                    "next_step_or_outcome": "Proceed to Step 3"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3a: Basic Controls and Replicates",
                    "extracted_paper_info": "In control assays, established kinases showed specific phosphorylation of their specific substrate. The experiments were performed with n = 4 independent experiments.",
                    "judgment": "Yes",
                    "reasoning": "Both normal (vector control) and abnormal (established kinases) controls were used, and the paper explicitly states that n = 4 independent experiments (replicates) were used.",
                    "next_step_or_outcome": "Proceed to Sub - step 3c"
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays - Sub - step 3c: Variant Controls",
                    "extracted_paper_info": "Wild - type (WT) was used as a control. Also, p.G2385R and p.R1628P (variants with increased kinase activity) were used in the study, which can be considered as controls relevant to the variant's effect on kinase activity.",
                    "judgment": "Yes",
                    "reasoning": "Wild - type and variants with different kinase activity were used as controls, meeting the criteria for variant controls.",
                    "next_step_or_outcome": "Proceed to Step 4"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation - Sub - step 4a: Statistical Analyses",
                    "extracted_paper_info": "p.R1398H had significantly lower kinase activity than WT (p < 0.001). Signals were analyzed using ImageQuant TL analysis software.",
                    "judgment": "Yes",
                    "reasoning": "Statistical analyses including p - values were used to compare the kinase activity of the variant with controls, which can be used to estimate OddsPath.",
                    "next_step_or_outcome": "Proceed to Sub - step 4c"
                },
                {
                    "step_name": "Step 4: Apply evidence to individual variant interpretation - Sub - step 4c: Correlate OddsPath",
                    "extracted_paper_info": "The kinase activity of p.R1398H was significantly lower than WT (p < 0.001). Although OddsPath is not directly given, the significant decrease in kinase activity relative to WT indicates a high likelihood of a protective (benign) effect.",
                    "judgment": "BS3_moderate",
                    "reasoning": "Based on the significant decrease in kinase activity compared to WT, assuming standard ACMG OddsPath thresholds, it can be inferred that the OddsPath is in the moderate range for a benign effect (as the decrease is significant).",
                    "next_step_or_outcome": "Final assessment"
                }
            ],
            "final_evidence_strength": {
                "type": "Benign",
                "strength": "BS3_moderate"
            },
            "overall_conclusion": "The functional evidence for LRRK2 R1398H is considered BS3_moderate because the disease mechanism is clearly defined, the in vitro kinase assay is applicable, proper controls and replicates were used, variant controls were present, statistical analyses were sufficient, and the significant decrease in kinase activity relative to WT indicates a moderate level of benignity likelihood."
        }
    ]
}